Related Experiment Videos
Multifocal fibrosclerosis with hypertrophic intracranial pachymeningitis
J R Berger1, S Snodgrass, J Glaser
1Department of Neurology, University of Miami School of Medicine, FL.
Abstract:
We describe a 34-year-old man with a 17-year history of multifocal fibrosclerosis resulting in unique neurologic complications. Episcleritis, orbital pseudotumor, and sclerosing cholangitis accompanied a florid intracranial inflammatory pachymeningitis. The latter was associated with blindness, multiple cranial neuropathies, pseudotumor cerebri, and seizures. Extensive investigation failed to reveal an etiology. Corticosteroids were ineffective in preventing progression of the disorder, and the value of antineoplastic therapy was uncertain. Multifocal fibrosclerosis, a rare disorder, may result in a confusing array of neurologic manifestations.
Insights
Multifocal fibrosclerosis is a rare condition that caused severe neurological issues in a patient. This case highlights the diverse and complex symptoms this disorder can present, posing diagnostic challenges.
Area of Science:
- Neurology
- Ophthalmology
- Gastroenterology
Background:
- Multifocal fibrosclerosis is a rare systemic fibrotic disease.
- It can affect various organs, leading to diverse clinical manifestations.
- Neurologic complications are uncommon but can be severe.
Observation:
- A 34-year-old man presented with a 17-year history of multifocal fibrosclerosis.
- He exhibited episcleritis, orbital pseudotumor, and sclerosing cholangitis.
- Florid intracranial inflammatory pachymeningitis was diagnosed.
Findings:
- The intracranial inflammation led to blindness, multiple cranial neuropathies, pseudotumor cerebri, and seizures.
- Despite extensive investigations, the etiology remained unknown.
- Corticosteroids were ineffective, and the role of antineoplastic therapy was unclear.
Implications:
- This case underscores the potential for multifocal fibrosclerosis to cause unusual and severe neurologic complications.
- It highlights the diagnostic challenges posed by this rare condition.
- Further research is needed to understand the pathogenesis and optimize treatment strategies.